HNF4α is a novel regulator of intestinal glucose-dependent insulinotropic polypeptide
Open Access
- 12 March 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 4200
Abstract
Mutations in the HNF4A gene cause MODY1 and are associated with an increased risk of Type 2 diabetes mellitus. On the other hand, incretins are hormones that potentiate reductions in blood glucose levels. Given the established role of incretin-based therapy to treat diabetes and metabolic disorders, we investigated a possible regulatory link between intestinal epithelial HNF4α and glucose-dependent insulinotropic polypeptide (GIP), an incretin that is specifically produced by gut enteroendocrine cells. Conditional deletion of HNF4α in the whole intestinal epithelium was achieved by crossing Villin-Cre and Hnf4αloxP/loxP C57BL/6 mouse models. GIP expression was measured by qPCR, immunofluorescence and ELISA. Gene transcription was assessed by luciferase and electrophoretic mobility shift assays. Metabolic parameters were analyzed by indirect calorimetry and dual-energy X-ray absorptiometry. HNF4α specific deletion in the intestine led to a reduction in GIP. HNF4α was able to positively control Gip transcriptional activity in collaboration with GATA-4 transcription factor. Glucose homeostasis and glucose-stimulated insulin secretion remained unchanged in HNF4α deficient mice. Changes in GIP production in these mice did not impact nutrition or energy metabolism under normal physiology but led to a reduction of bone area and mineral content, a well described physiological consequence of GIP deficiency. Our findings point to a novel regulatory role between intestinal HNF4α and GIP with possible functional impact on bone density.Keywords
Funding Information
- Canadian Institutes of Health Research (PJT-156180)
- Natural Sciences and Engineering Research Council of Canada (RGPIN-2017-06096)
This publication has 53 references indexed in Scilit:
- MODYDiabetes Care, 2011
- Hepatic Hepatocyte Nuclear Factor 4α Is Essential for Maintaining Triglyceride and Cholesterol HomeostasisArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Modification in Oxidative Stress, Inflammation, and Lipoprotein Assembly in Response to Hepatocyte Nuclear Factor 4α Knockdown in Intestinal Epithelial CellsJournal of Biological Chemistry, 2010
- Loss of Hepatocyte-Nuclear-Factor-4α Affects Colonic Ion Transport and Causes Chronic Inflammation Resembling Inflammatory Bowel Disease in MicePLOS ONE, 2009
- Identification of an Endogenous Ligand Bound to a Native Orphan Nuclear ReceptorPLOS ONE, 2009
- GATA-4 upregulates glucose-dependent insulinotropic polypeptide expression in cells of pancreatic and intestinal lineageMolecular and Cellular Endocrinology, 2008
- Cooperative Interaction between Hepatocyte Nuclear Factor 4 α and GATA Transcription Factors Regulates ATP-Binding Cassette Sterol Transporters ABCG5 and ABCG8Molecular and Cellular Biology, 2007
- Hepatocyte Nuclear Factor 4α Is Essential for Embryonic Development of the Mouse ColonGastroenterology, 2006
- Hepatocyte nuclear factor 4α controls the development of a hepatic epithelium and liver morphogenesisNature Genetics, 2003
- Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1)Nature, 1996